Janssen Wants To Combine Celltrion Biosimilar Patent Suits
Janssen Biotech Inc. on Thursday asked a Massachusetts federal court to combine two patent cases it's bringing against Celltrion Healthcare Co. and Hospira Inc. over Inflectra, the defendants' biosimilar of Janssen's...To view the full article, register now.
Already a subscriber? Click here to view full article